MedTrace Logo

Evaluation of SCOUT DS Device in the Diagnosis of Diabetes Mellitus

NCT01572415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 409

Last updated 2012-12-05

No results posted yet for this study

Summary

The primary objective is to identify compare SCOUT DS to random capillary glucose for identification of at-risk subjects with dysglycemia defined by hemoglobin A1C ≥ 6.0%.

Conditions

Sponsors & Collaborators

  • Greece National Social Insurance Institute

    collaborator UNKNOWN

  • Laikο General Hospital, Athens

    collaborator OTHER

  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • Nicholas Tentolouris, MD · LAIKO General Hospital/University of Athens

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572415 on ClinicalTrials.gov